29.03.2013 • NewsArkemaKem OneKlesch

Arkema Clarification of Kem One Situation

The Lyon commercial court has decided to open insolvency proceedings with continuation of activities for a six-month observation period against the company Kem One, corresponding to the upstream part (chlorine / caustic soda electrolysis and PVC production) of the various businesses sold by Arkema to the Klesch Group.

Arkema points out that the divestment of the vinyl activities to the Klesch Group, finalized on July 2 2012, concerned a comprehensive industrial package coherent from an economic point of view, from upstream (chlorine / caustic soda electrolysis and PVC production) to downstream (PVC converting into compounds, pipes and profiles). Maintaining this integration was a key factor of Kem One's future success.

The Kem One group had a robust balance sheet at the time of the divestment (without any debt, a €100 million cash contribution, and many guarantees), and the Klesch Group made a commitment to develop a financing plan adapted to the needs of Kem One as from July 2012.

Arkema points out that the situation created today results from a unilateral act by the Klesch Group which has decided to split up the upstream (Kem One) and downstream (Kem One Innovative Vinyls) activities and not to put in place the contemplated funding and guarantees.

Arkema therefore expects that these insolvency proceedings will help clarify the reasons for the current situation (operation of the plants, management of the Lavra steamcracker force majeure event, evolution of margins and volumes), and trusts that they will also help ensure without delay that the financial resources made available to Kem One by Arkema have been used in accordance with their corporate purpose.

Arkema points out that the sale of the vinyl activities to the Klesch Group in July 2012 was completed in full transparency, in full regularity and in full compliance with the standard practices for this type of transactions, and is perfectly confident in its ability to demonstrate the same.

Finally, Arkema points out that its exposure to Kem One as at 31 December 2012, without any increase since, amounts to €125 million in total, corresponding to €65 million in receivables and €60 million in guarantees granted to third parties.

 

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.